Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC
出版年份 2014 全文链接
标题
Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC
作者
关键词
-
出版物
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 6, Pages 3091-3099
出版商
American Society for Microbiology
发表日期
2014-03-18
DOI
10.1128/aac.02462-13
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones
- (2013) Xavier Mulet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2011-2012)
- (2013) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort
- (2013) Carmen Peña et al. CLINICAL INFECTIOUS DISEASES
- Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli
- (2013) George G. Zhanel et al. DRUGS
- Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study
- (2013) Mikhail V Edelstein et al. LANCET INFECTIOUS DISEASES
- Pan-β-Lactam Resistance Development in Pseudomonas aeruginosa Clinical Strains: Molecular Mechanisms, Penicillin-Binding Protein Profiles, and Binding Affinities
- (2012) Bartolomé Moyá et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones
- (2012) Gabriel Cabot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Pseudomonas aeruginosa Transcriptome in Planktonic Cultures and Static Biofilms Using RNA Sequencing
- (2012) Andreas Dötsch et al. PLoS One
- Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study
- (2011) Gabriel Cabot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of Intracellular Proteases in the Antibiotic Resistance, Motility, and Biofilm Formation of Pseudomonas aeruginosa
- (2011) Lucía Fernández et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa
- (2010) B. Moya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of a New Cephalosporin, CXA-101 (FR264205), against -Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after Antipseudomonal Treatment of Intensive Care Unit Patients
- (2010) B. Moya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Determinants Involved in the Susceptibility of Pseudomonas aeruginosa to -Lactam Antibiotics
- (2010) C. Alvarez-Ortega et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients
- (2010) L. Zamorano et al. CLINICAL MICROBIOLOGY AND INFECTION
- Stampy: A statistical algorithm for sensitive and fast mapping of Illumina sequence reads
- (2010) G. Lunter et al. GENOME RESEARCH
- Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1
- (2010) E. Riera et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes
- (2010) G. L. Winsor et al. NUCLEIC ACIDS RESEARCH
- Differential expression analysis for sequence count data
- (2010) Simon Anders et al. GENOME BIOLOGY
- In Vitro Potency of CXA-101, a Novel Cephalosporin, against Pseudomonas aeruginosa Displaying Various Resistance Phenotypes, Including Multidrug Resistance
- (2009) C. C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of a New Antipseudomonal Cephalosporin, CXA-101 (FR264205), against Carbapenem-Resistant and Multidrug-Resistant Pseudomonas aeruginosa Clinical Strains
- (2009) C. Juan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genomewide Identification of Genetic Determinants of Antimicrobial Drug Resistance in Pseudomonas aeruginosa
- (2009) A. Dotsch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Sequence Alignment/Map format and SAMtools
- (2009) H. Li et al. BIOINFORMATICS
- Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
- (2009) P. D. Lister et al. CLINICAL MICROBIOLOGY REVIEWS
- Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates
- (2009) David M. Livermore et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Benefit of Having Multiple ampD Genes for Acquiring -Lactam Resistance without Losing Fitness and Virulence in Pseudomonas aeruginosa
- (2008) B. Moya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Complex Ciprofloxacin Resistome Revealed by Screening a Pseudomonas aeruginosa Mutant Library for Altered Susceptibility
- (2008) E. B. M. Breidenstein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa
- (2008) D. Qiu et al. MICROBIOLOGY-SGM
- The Neglected Intrinsic Resistome of Bacterial Pathogens
- (2008) Alicia Fajardo et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started